C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions

Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
05/2011
05/19/2011	US20110117111 Microrna-based diagnostic testing and therapies for inflammatory bowel disease and related diseases
05/19/2011	US20110117095 Growth factor htter36
05/19/2011	US20110117083 Biological markers for monitoring patient response to vegf antagonists
05/19/2011	US20110117066 Established human brown adipocyte line and method for differentiation from an hmads cell line
05/19/2011	US20110117064 Assay for the prediction of therapeutic effectiveness of mesenchymal stromal cells, and methods of using same
05/19/2011	US20110117056 Diagnosis and treatment of diseases or disorders associated with xenotropic murine leukemia virus
05/19/2011	US20110117054 Use of ribavirin in blood coagulation disorder
05/19/2011	US20110117049 Methods and Compositions for Modulating Adipocyte Function
05/19/2011	US20110117026 Methods and compositions for the delivery of bioactive compounds
05/19/2011	US20110117025 Device and method for fluorescence-based imaging and monitoring
05/19/2011	US20110117023 Contrast agent for photoacoustic imaging and photoacoustic imaging method using the same
05/19/2011	US20110117013 Compositions against cancer antigen liv-1 and uses thereof
05/19/2011	US20110116694 Rapid confocal microscopy to support surgical procedures
05/19/2011	US20110114244 Self-assembly of macromolecules on multilayered polymer surfaces
05/19/2011	DE112008000888T5 Nichtspezifische verzögerte Überempfindlichkeitsreaktion zur Behandlung von Herpes-Simplex-Virusinfektionen Non-specific delayed hypersensitivity response for the treatment of herpes simplex virus infections
05/19/2011	DE10362020B4 Testsystem zur Untersuchung der Biofilmhydrolyse Test system to investigate the Biofilmhydrolyse
05/19/2011	DE10296990B4 Verwendung eines Biochips zur Diagnose von Sepsis und sepsisähnlichem Syndrom Using a biochip for the diagnosis of sepsis and sepsis-like syndrome
05/19/2011	DE102009054098A1 Nachweis von Mykobakterien und deren Resistenzgenen Detection of mycobacteria and their resistance genes
05/19/2011	CA2786118A1 Methods for pcr and hla typing using raw blood
05/19/2011	CA2780875A1 Molecular biomarkers for predicting response to tyrosine kinase inhibitors in lung cancer
05/19/2011	CA2780541A1 Methods and compositions for expanding, identifying, characterizing and enhancing potency of mammalian-derived glial restricted progenitor cells
05/19/2011	CA2780479A1 Signature for the diagnosis of breast cancer aggressiveness and genetic instability
05/19/2011	CA2780430A1 Genes differentially expressed by cumulus cells and assays using same to identify pregnancy competent oocytes
05/19/2011	CA2780044A1 Biomarkers for predicting rapid response to hcv treatment
05/19/2011	CA2779606A1 Heart aging biomarkers and methods of use
05/19/2011	CA2779293A1 Solution assay and high through-put screen to probe interaction between human cullin-ring ligase complex and hiv-vif protein
05/19/2011	CA2779274A1 Nucleic acid probes and methods for detecting plasmodium parasites
05/19/2011	CA2779255A1 Rapid detection of mycoplasma contamination in cell culture samples
05/19/2011	CA2778839A1 Glycosyl transferase from chinese hamster and related methods
05/19/2011	CA2777549A1 Copy number analysis of genetic locus
05/18/2011	EP2323070A2 Counting biological agents on biological growth plates
05/18/2011	EP2322940A1 Systems amd methods to perform assays for detecting or quantifing analytes within samples
05/18/2011	EP2322933A1 Diagnosis of carcinomas
05/18/2011	EP2322930A2 Sequences for detection and identification of methicillin-resistant Staphylococcus Aureus (MRSA) of MREJ type xiv
05/18/2011	EP2322929A1 Diagnostics, drug screening and treatment for cancer
05/18/2011	EP2322921A1 DNTP conjugated to peptide via a UV cleavable linker
05/18/2011	EP2322920A1 MALDI tissue imaging using conjugates cleavable by fast fragmentation
05/18/2011	EP2322670A2 Method for typing and detecting HBV
05/18/2011	EP2322669A2 Method for typing and detecting HBV
05/18/2011	EP2322668A2 Highly conserved gene and its use to generate species-specific, genus-specific, family-specific, group-specific and universal nucleic acid probes for microorganisms.
05/18/2011	EP2322667A2 Highly conserved gene and its use to generate species-specific, genus-specific, family-specific, group-specific and universal nucleic acid probes for microorganisms.
05/18/2011	EP2322666A2 Highly conserved gene and its use to generate species-specific, genus-specific, family-specific, group-specific and universal nucleic acid probes for microorganisms.
05/18/2011	EP2322665A1 MicroRNAs and uses thereof
05/18/2011	EP2322664A1 Methods and sequences for the detection and identification of methicillin-resistant Staphylococcus aureus MREJ type vi strains
05/18/2011	EP2322663A1 Methods and sequences for the detection and identification of methicillin-resistant Staphylococcus aureus MREJ type v strains
05/18/2011	EP2322662A1 MicroRNAs and uses thereof
05/18/2011	EP2322661A1 Methods and sequences for the detection and identification of methicillin-resistant Staphylococcus aureus MREJ type ix strains
05/18/2011	EP2322660A1 MicroRNAs and uses thereof
05/18/2011	EP2322659A1 Method and specimen for detecting sensitivity to isoniazid in tubercle bacillus
05/18/2011	EP2322658A1 Signature for the diagnosis of breast cancer aggressiveness and genetic instability
05/18/2011	EP2322657A1 Methods and sequences to preferentially suppress expression of mutated huntingtin gene.
05/18/2011	EP2322656A1 Methods for diagnosing skin diseases
05/18/2011	EP2322655A1 Methods and sequences for the detection and identification of methicillin-resistant Staphylococcus aureus MREJ type viii strains
05/18/2011	EP2322654A1 MicroRNAs and uses thereof
05/18/2011	EP2322653A1 MicroRNAs and uses thereof
05/18/2011	EP2322652A1 MicroRNAs and uses thereof
05/18/2011	EP2322651A1 MicroRNAs and uses thereof
05/18/2011	EP2322650A1 MicroRNAs and uses thereof
05/18/2011	EP2322649A1 Method for rapid detection and identification of bioagents
05/18/2011	EP2322648A1 RNA aptamers and methods for identifying the same
05/18/2011	EP2322647A2 PCR method and PCR device
05/18/2011	EP2322646A1 Method of detecting platelet thrombosis or organ failure
05/18/2011	EP2322645A1 Mass transport limited in vivo analyte sensor
05/18/2011	EP2322632A2 Glufosinate tolerant rice
05/18/2011	EP2322631A1 In vivo incorporation of unnatural amino acids
05/18/2011	EP2322630A2 Polypeptides having xylanase activity and polynucleotides encoding same
05/18/2011	EP2322628A2 Mutations in the BCR-ABL tyrosine kinase associated with resistance to STI-571
05/18/2011	EP2322627A2 Mutations in the BCR-abl tyrosine kinase associated with resistance to STI-571
05/18/2011	EP2322615A1 Use of unmethylated CpG oligonucleotides for the treatment of allergy
05/18/2011	EP2322605A2 Terpene synthases
05/18/2011	EP2322555A1 Antibodies specific for claudin 6 (CLDN6)
05/18/2011	EP2322544A2 Differential in tumour gene products and use of same
05/18/2011	EP2322540A1 Lactobacillus acidophilus nucleic acids encoding fructo-oligosaccharide utilization compounds and uses thereof
05/18/2011	EP2322539A2 A method for identification, isolation and production of antigens to a specific pathogen
05/18/2011	EP2322535A2 Riboswitches, methods for their use, and compositions for use with riboswitches
05/18/2011	EP2322529A1 Selective glycosidase inhibitors and uses thereof
05/18/2011	EP2322278A2 Apparatus and Method for Dispensing Fluid, Semi-Solid and Solid Samples
05/18/2011	EP2322224A1 Potentiator of activity of anti-cancer agent and use thereof, and biomarker for prediction of prognosis in cancer patient and use thereof
05/18/2011	EP2322218A1 Methods of modulating CD200 receptors
05/18/2011	EP2322209A2 Tumor specific oligosaccharide epitopes and use thereof
05/18/2011	EP2321789A1 Methods and systems for assessment of clinical infertility
05/18/2011	EP2321645A1 Susceptibility to hsp90-inhibitors
05/18/2011	EP2321642A1 Methods for allele calling and ploidy calling
05/18/2011	EP2321641A2 Gene methylation in cancer diagnosis
05/18/2011	EP2321434A2 Methods for sequencing individual nucleic acids under tension
05/18/2011	EP2321433A2 Diagnostics and treatments for vegf-independent tumors
05/18/2011	EP2321432A1 Method for detecting chromosomal abnormalities
05/18/2011	EP2321431A2 Methods and nucleic acids for analyses of cell proliferative disorders
05/18/2011	EP2321430A2 Method of evaluating oral cancer risk in human
05/18/2011	EP2321429A2 Methods and kits for nucleic acid sequencing
05/18/2011	EP2321428A1 Method for detection of cancer based on spatial genome organization
05/18/2011	EP2321427A2 Methods for digital pcr
05/18/2011	EP2321426A1 Compositions for detecting cell death and methods of use thereof
05/18/2011	EP2321425A1 Carrier neutralization/modification in antimicrobial compositions, articles and methods
05/18/2011	EP2321424A1 Determining the sensitivity of a cell to a drug
05/18/2011	EP2321423A1 Method of detecting bioactive molecules in a fluid sample
05/18/2011	EP2321411A1 Melk epitope peptides and vaccines containing the same
05/18/2011	EP2321410A1 Ect2 oncogene as a therapeutic target and prognostic indicator for lung and esophageal cancer
05/18/2011	EP2321406A1 Method for selecting secondary neurosphere derived from differentiated cell-derived pluripotent stem cell, clone selected by the method and use of the clone
05/18/2011	EP2321332A1 Self-avoiding molecular recognition systems in dna amplification

1 ... 643 644 645 646 647 648 649 650 651 652 653 654 655 656 657 658 659 660 661 662 663 ... 3003